Ocular Therapeutix Cash from Financing (TTM) Insights

Ocular Therapeutix Inc (OCUL)

5.00 -0.08 (-1.48%) USD | NASDAQ | Apr 23, 16:00

4.995 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	169.83M
September 30, 2023	62.12M
June 30, 2023	10.56M
March 31, 2023	1.403M
December 31, 2022	1.454M
September 30, 2022	1.663M
June 30, 2022	1.968M
March 31, 2022	4.142M
December 31, 2021	2.851M
September 30, 2021	166.10M
June 30, 2021	165.64M
March 31, 2021	214.03M
December 31, 2020	228.01M
September 30, 2020	73.19M
June 30, 2020	91.58M
March 31, 2020	45.86M
December 31, 2019	75.34M
September 30, 2019	82.58M
June 30, 2019	75.34M
March 31, 2019	76.71M
December 31, 2018	68.64M

Date	Value
September 30, 2018	53.52M
June 30, 2018	43.67M
March 31, 2018	37.76M
December 31, 2017	32.01M
September 30, 2017	31.50M
June 30, 2017	30.04M
March 31, 2017	29.25M
December 31, 2016	0.585M
September 30, 2016	0.20M
June 30, 2016	-0.079M
March 31, 2016	65.65M
December 31, 2015	65.70M
September 30, 2015	65.29M
June 30, 2015	133.04M
March 31, 2015	79.27M
December 31, 2014	78.97M
September 30, 2014	78.63M
June 30, 2014	10.62M
March 31, 2014	6.705M
December 31, 2013	6.683M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.403M

Minimum

Mar 2023

228.01M

Maximum

Dec 2020

77.56M

Average

73.19M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks